PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Cancer Research and Treatment10.4143/crt.2016.1212017492416-422Phase II Study of Irinotecan and Cisplatin Combination Chemotherapy in Metastatic, Unresectable Esophageal CancerMiso Kim, Bhumsuk Keam, Tae-Min Kim, Hoon-Gu Kim, Jin-Soo Kim, Sung Sook Lee, Seong Hoon Shin, Min Kyoung Kim, Keon Uk Park, Dong-Wan Kim, Hwan Jung Yun, Jong Seok Lee, Dae Seog Heohttp://www.e-crt.org/journal/view.php?doi=10.4143/crt.2016.121, http://www.e-crt.org/upload/pdf/crt-2016-121.pdf, http://www.e-crt.org/upload/pdf/crt-2016-121.pdf
Lung Cancer10.1016/0169-5002(94)94254-4199411126A phase I trial of combination chemotherapy with irinotecan(CPT-II). Cisplatin and vindesine in advanced non-small cell lung cancer (NSCLC)https://api.elsevier.com/content/article/PII:0169500294942544?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:0169500294942544?httpAccept=text/plain
Cancer10.1002/(sici)1097-0142(19960501)77:9<1959::aid-cncr32>3.0.co;2-x19967791959-1960Prospective study of combination chemotherapy with cyclophosphamide, doxorubicin, and cisplatin for unresectable or metastatic malignant pleural mesotheliomaAjay Anand, Abhay Anand, Namrata Anandhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F(SICI)1097-0142(19960501)77:9%3C1959::AID-CNCR32%3E3.0.CO;2-X, https://onlinelibrary.wiley.com/doi/full/10.1002/(SICI)1097-0142(19960501)77:9%3C1959::AID-CNCR32%3E3.0.CO;2-X
Lung Cancer10.1016/s0169-5002(03)92176-3200341S143-S144P-207 Docetaxel and irinotecan as first line chemotherapy in patients with unresectable locally advanced or metastatic non small cell lung cancer (NSCLC): A phase II studyGesine Groth, Martin Reck, Hansjochen Wilke, Thomas Büchele, Klaus Schäfer, Ulrich Gatzemeierhttps://api.elsevier.com/content/article/PII:S0169500203921763?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0169500203921763?httpAccept=text/plain
Gynecologic Oncology10.1016/s0090-8258(03)00174-42003893402-407Phase II clinical study of irinotecan and cisplatin as first-line chemotherapy in metastatic or recurrent cervical cancerImjai Chitapanarux, Anun Tonusin, Vimol Sukthomya, Chamita Charuchinda, Nantaka Pukanhapan, Vicharn Lorvidhayahttps://api.elsevier.com/content/article/PII:S0090825803001744?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0090825803001744?httpAccept=text/plain
British Journal of Cancer10.1038/bjc.2016.1252016114111185-1190Vorinostat in combination with capecitabine plus cisplatin as a first-line chemotherapy for patients with metastatic or unresectable gastric cancer: phase II study and biomarker analysisChanghoon Yoo, Min-Hee Ryu, Young-Soon Na, Baek-Yeol Ryoo, Chae-Won Lee, Yoon-Koo Kanghttp://www.nature.com/articles/bjc2016125.pdf, http://www.nature.com/articles/bjc2016125, http://www.nature.com/articles/bjc2016125.pdf
Lung Cancer10.1016/0169-5002(94)94265-x199411128Phase II study of chemotherapy with VP16, ifosfamide and cisplatin (VIP) in the treatment of unresectable advanced non small cell lung cancerhttps://api.elsevier.com/content/article/PII:016950029494265X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:016950029494265X?httpAccept=text/plain
Gastric Cancer10.1007/s10120-006-0379-2200693203-207Combination chemotherapy with irinotecan and cisplatin in pretreated patients with unresectable or recurrent gastric cancerShinya Ueda, Shuichi Hironaka, Narikazu Boku, Akira Fukutomi, Takayuki Yoshino, Yusuke Onozawahttp://link.springer.com/content/pdf/10.1007/s10120-006-0379-2.pdf, http://link.springer.com/article/10.1007/s10120-006-0379-2/fulltext.html, http://link.springer.com/content/pdf/10.1007/s10120-006-0379-2
Chonnam Medical Journal10.4068/cmj.2009.45.2.79200945279Phase II Study of Irinotecan, High-dose 5-fluorouracil, and Leucovorin Combination Chemotherapy in Taxane and Cisplatin-based Chemotherapy-refractory Metastatic Gastric CancerJu-Young Yoon, Sung-Ji Lee, Dae-Ho Cho, Sung-Yoon Rew, Dae-Eun Kim, Jun-Eul Hwang, Woo-Kyun Bae, Hyun-Jeong Shim, Sang-Hee Cho, Ik-Joo Chunghttps://synapse.koreamed.org/DOIx.php?id=10.4068/cmj.2009.45.2.79, https://synapse.koreamed.org/pdf/10.4068/cmj.2009.45.2.79, https://cmj.ac.kr/DOIx.php?id=10.4068/cmj.2009.45.2.79
Lung Cancer10.1016/s0169-5002(85)80114-8198513-482Unresectable non metastatic squamous cell carcinoma of the lung: Phase II study of radical radiotherapy and combined chemotherapyhttps://api.elsevier.com/content/article/PII:S0169500285801148?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0169500285801148?httpAccept=text/plain